Communication with patients with limited prognosis-an integrative mixed-methods evaluation study.

Communication Lung cancer Mixed methods Palliative medicine Prognosis Terminal illness

Journal

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
ISSN: 1433-7339
Titre abrégé: Support Care Cancer
Pays: Germany
ID NLM: 9302957

Informations de publication

Date de publication:
22 Dec 2022
Historique:
received: 27 06 2022
accepted: 25 11 2022
entrez: 22 12 2022
pubmed: 23 12 2022
medline: 27 12 2022
Statut: epublish

Résumé

Oncological societies advocate the continuity of care, specialized communication, and early integration of palliative care. To comply with these recommendations, an interprofessional, longitudinally-structured communication concept, the Milestone Communication Approach (MCA), was previously developed, implemented, and evaluated. Our research question is: what are possible explanations from the patient perspective for prognosis and advance care planning being rarely a topic and for finding no differences between MCA and control groups concerning distress, quality of life, and mood? A pragmatic epistemological stance guided the study. A mixed-methods design was chosen including a pragmatic randomized trial (n = 171), qualitative interviews with patients (n = 13) and caregivers (n = 12), and a content analysis (133 milestone conversations, 54 follow-up calls). Data analysis involved the pillar integration process. Two pillar themes emerged: 1 "approaching prognosis and advance care planning"; 2 "living with a life-threatening illness". Information on prognosis seemed to be offered, but patients' reactions were diverse. Some patients have to deal with having advanced lung cancer while nonetheless feeling healthy and seem not to be ready for prognostic information. All patients seemed to struggle to preserve their quality of life and keep distress under control. Attending to patients' questions, worries and needs early in a disease trajectory seems key to helping patients adjust to living with lung cancer. If necessary clinicians should name their predicament: having to inform about prognosis versus respecting the patients wish to avoid it. Research should support better understanding of patients not wishing for prognostic information to successfully improve communication strategies. Registration: German Clinical Trial Register No. DRKS00013649, registration date 12/22/2017, ( https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00013649 ) and No. DRKS00013469, registration date 12/22/2017, ( https://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00013469 ).

Identifiants

pubmed: 36547732
doi: 10.1007/s00520-022-07474-9
pii: 10.1007/s00520-022-07474-9
pmc: PMC9780125
doi:

Types de publication

Journal Article Pragmatic Clinical Trial Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

77

Subventions

Organisme : German National Center for Tumor diseases
ID : NCT 3.0, G835
Organisme : German National Center for Tumor diseases
ID : NCT 3.0, G835
Organisme : German National Center for Tumor diseases
ID : NCT 3.0, G835
Organisme : German Federal Ministry for Health
ID : No. 1504-54401
Organisme : German Federal Ministry for Health
ID : No. 1504-54401
Organisme : German Federal Ministry for Health
ID : No. 1504-54401
Organisme : German Federal Ministry for Health
ID : No. 1504-54401
Organisme : German Federal Ministry for Health
ID : No. 1504-54401

Informations de copyright

© 2022. The Author(s).

Références

Ferlay J, Colombet M, Soerjomataram I, Dyba T, Randi G, Bettio M et al (2018) Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer 103:356–387
doi: 10.1016/j.ejca.2018.07.005
Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M et al (2018) Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet 391(10125):1023–1075
doi: 10.1016/S0140-6736(17)33326-3
Arbour KC, Riely GJ (2019) Systemic therapy for locally advanced and metastatic non-small cell lung cancer: a review. JAMA 322(8):764–774
doi: 10.1001/jama.2019.11058
AWMF (2020) Erweiterte S3-Leitlinie Palliativmedizin für Patienten mit einer nicht heilbaren Krebserkrankung
Peppercorn JM, Smith TJ, Helft PR, DeBono DJ, Berry SR, Wollins DS et al (2011) American Society of Clinical Oncology statement: toward individualized care for patients with advanced cancer. J Clin Oncol 29(6):755–760
doi: 10.1200/JCO.2010.33.1744
Weeks JC, Catalano PJ, Cronin A, Finkelman MD, Mack JW, Keating NL et al (2012) Patients’ expectations about effects of chemotherapy for advanced cancer. N Engl J Med 367(17):1616–25. https://doi.org/10.1056/NEJMoa1204410
doi: 10.1056/NEJMoa1204410
Nehls W, Gabrijel S, Kiss A, Kollmeier J, Schmalz O, Albrecht H et al (2013) Physician communication in a lung cancer center–does the message come across? Pneumologie 67(12):688–693
doi: 10.1055/s-0033-1358999
Davison SN (2006) Facilitating advance care planning for patients with end-stage renal disease: the patient perspective. Clin J Am Soc Nephrol 1(5):1023–1028
doi: 10.2215/CJN.01050306
Jackson VA, Jacobsen J, Greer JA, Pirl WF, Temel JS, Back AL (2013) The cultivation of prognostic awareness through the provision of early palliative care in the ambulatory setting: a communication guide. J Palliat Med 16(8):894–900
doi: 10.1089/jpm.2012.0547
Morrison RS, Meier DE, Arnold RM (2021) What’s wrong with advance care planning? JAMA 326(16):1575–1576
doi: 10.1001/jama.2021.16430
Bernacki RE, Block SD (2014) Communication about serious illness care goals: a review and synthesis of best practices. JAMA Intern Med 174(12):1994–2003
doi: 10.1001/jamainternmed.2014.5271
Bernacki R, Hutchings M, Vick J, Smith G, Paladino J, Lipsitz S et al (2015) Development of the serious illness care program: a randomised controlled trial of a palliative care communication intervention. BMJ Open 5(10):e009032
doi: 10.1136/bmjopen-2015-009032
Baile WF, Buckman R, Lenzi R, Glober G, Beale EA, Kudelka AP (2000) SPIKES—a six-step protocol for delivering bad news: application to the patient with cancer. Oncologist 5:302–311
doi: 10.1634/theoncologist.5-4-302
Grimshaw JM, Eccles MP, Lavis JN, Hill SJ, Squires JE (2012) Knowledge translation of research findings. Implement Sci 7(50):1–17
Grol R, Wensing M (2013) Effective implementation of change in healthcare: a systematic approach. In: Grol R, Wensing M, Eccles M, Davis D, editors. Improving patient care. 2nd ed: Wiley Blackwell BMJ Books; p. 40–63
Creswell JW, Plano Clark VL (2018) Designing and conducting mixed methods research, 3rd edn. Sage, Thousand Oaks, CA, USA
Bazeley P (2009) Editorial: integrating data analyses in mixed methods research. J Mix Methods Res 3(3):203–7
Johnson RE, Grove AL, Clarke A (2019) Pillar integration process: a joint display technique to integrate data in mixed methods research. J Mix Methods Res 13(3):301–20
Krug K, Bossert J, Deis N, Krisam J, Villalobos M, Siegle A et al (2021) Effects of an interprofessional communication approach on support needs, quality of life, and mood of patients with advanced lung cancer: a randomized trial. Oncologist. 26(26):e1445–e59
doi: 10.1002/onco.13790
Krug K, Bossert J, Stooß L, Siegle A, Villalobos M, Hagelskamp L et al (2020) Consideration of sense of coherence in a structured communication approach with stage IV lung cancer patients and their informal caregivers: a qualitative interview study. Support Care Cancer 29:2153–2159.  https://doi.org/10.1007/s00520-020-05724-2
Bossert J, Wensing M, Thomas M, Villalobos M, Jung C, Siegle A et al (2020) Implementation of the milestones communication approach for patients with limited prognosis: evaluation of intervention fidelity. BMC Palliat Care 19(1):21
doi: 10.1186/s12904-020-0527-1
Tessmer G, Zaba O, Grohé C (2011) Konzept einer vorausschauenden Kommunikation in der palliativen Behandlung von Patienten mit pneumolgisch-onkologischen Erkrankung. Pneumologie 65:503–509
doi: 10.1055/s-0030-1256307
Siegle A, Villalobos M, Bossert J, Krug K, Hagelskamp L, Krisam J et al (2018) The Heidelberg Milestones Communication Approach (MCA) for patients with prognosis <12 months: protocol for a mixed-methods study including a randomized controlled trial. Trials 19(1):1–13
doi: 10.1186/s13063-018-2814-1
Bausewein C, Fegg M, Radbruch L, Nauck F, von Mackensen S, Borasio GD et al (2005) Validation and clinical application of the German version of the palliative care outcome scale. J Pain Symptom Manage 30(1):51–62
doi: 10.1016/j.jpainsymman.2005.01.017
Villalobos M, Siegle A, Hagelskamp L, Handtke V, Jung C, Krug K et al (2019) HeiMeKOM (Heidelberger Meilenstein Kommunikation): Entwicklung einer interprofessionellen Intervention zur Verbesserung der Kommunikation bei Patient*innen mit eingeschränkter Prognose. Z Evid Fortbild Qual Gesundhwes 147–148:28–33
doi: 10.1016/j.zefq.2019.06.006
O’Cathain A, Murphy E, Nicholl J (2008) The quality of mixed methods studies in health services research. J Health Serv Res Policy 13(2):92–98
doi: 10.1258/jhsrp.2007.007074
Braun V, Clarke V (2006) Using thematic analysis in psychology. Qual Res Psychol 3(2):77–101
doi: 10.1191/1478088706qp063oa
Jacobsen J, Jackson VA (2009) A communication approach for oncologists: understanding patient coping and communicating about bad news, palliative care, and hospice. J Natl Compr Cancer Network: JNCCN 7(4):475–480
doi: 10.6004/jnccn.2009.0032
Hofmann JC, Wenger NS, Davis RB, Teno J, Connors Jr AF, Desbiens N et al (1997) Patient preferences for communication with physicians about end-of-life decisions. SUPPORT Investigators. Study to Understand Prognoses and Preference for Outcomes and Risks of Treatment. Ann Intern Med 127(1):1–12
doi: 10.7326/0003-4819-127-1-199707010-00001
Fried TR, Bradley EH, O’Leary J (2006) Changes in prognostic awareness among seriously ill older persons and their caregivers. J Palliat Med 9(1):61–69
doi: 10.1089/jpm.2006.9.61
Kvåle K (2007) Do cancer patients always want to talk about difficult emotions? A qualitative study of cancer inpatients communication needs. Eur J Oncol Nurs 11(4):320–327
doi: 10.1016/j.ejon.2007.01.002
Rietjens JAC, Sudore RL, Connolly M, van Delden JJ, Drickamer MA, Droger M et al (2017) Definition and recommendations for advance care planning: an international consensus supported by the European Association for Palliative Care. Lancet Oncol 18(9):e543–e551
doi: 10.1016/S1470-2045(17)30582-X
van Roij J, Brom L, Youssef-El Soud M, van de Poll-Franse L, Raijmakers NJH (2019) Social consequences of advanced cancer in patients and their informal caregivers: a qualitative study. Support Care Cancer 27(4):1187–1195
doi: 10.1007/s00520-018-4437-1
Horne G, Seymour J, Payne S (2012) Maintaining integrity in the face of death: a grounded theory to explain the perspectives of people affected by lung cancer about the expression of wishes for end of life care. Int J Nurs Stud 49(6):718–726
doi: 10.1016/j.ijnurstu.2011.12.003
Nierop-van Baalen C, Grypdonck M, van Hecke A, Verhaeghe S (2016) Hope dies last … A qualitative study into the meaning of hope for people with cancer in the palliative phase. Eur J Cancer Care 25(4):570–79
doi: 10.1111/ecc.12500
El-Jawahri A, Traeger L, Park ER, Greer JA, Pirl WF, Lennes IT et al (2014) Associations among prognostic understanding, quality of life, and mood in patients with advanced cancer. Cancer 120(2):278–285
doi: 10.1002/cncr.28369
Vos MS, Putter H, van Houwelingen HC, de Haes HC (2011) Denial and social and emotional outcomes in lung cancer patients: the protective effect of denial. Lung Cancer 72(1):119–124
doi: 10.1016/j.lungcan.2010.07.007
Ferrell BR, Temel JS, Temin S, Alesi ER, Balboni TA, Basch EM et al (2017) Integration of palliative care into standard oncology care. Am Soc Clin Oncol Clin Pract Guidel Update 35(1):96–112
doi: 10.1200/JCO.2016.70.1474
AWMF, DKG, DKH. S3-Leitlinie Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms 2018 [Available from: http://leitlinienprogramm-onkologie.de/Lungenkarzinom.98.0.html . Accessed 20 June 2022
Beauchamp T, Childress J (2019) Principles of biomedical ethics: marking its fortieth anniversary. Am J Bioeth: AJOB 19(11):9–12
doi: 10.1080/15265161.2019.1665402
Pfeil TA, Laryionava K, Reiter-Theil S, Hiddemann W, Winkler EC (2015) What keeps oncologists from addressing palliative care early on with incurable cancer patients? An active stance seems key. Oncologist 20(1):56–61
doi: 10.1634/theoncologist.2014-0031
Innes S, Payne S (2009) Advanced cancer patients’ prognostic information preferences: a review. Palliat Med 23(1):29–39
doi: 10.1177/0269216308098799
Heyland DK, Ilan R, Jiang X, You JJ, Dodek P (2016) The prevalence of medical error related to end-of-life communication in Canadian hospitals: results of a multicentre observational study. BMJ Qual Saf 25(9):671–679
doi: 10.1136/bmjqs-2015-004567

Auteurs

Anja Siegle (A)

Department of Thoracic Oncology, University Hospital Heidelberg, Thoracic Clinic, Translational Lung Research Center Heidelberg (TLRC-H), German Center for Lung Research (DZL), Heidelberg, Germany. Anja.siegle@med.uni-heidelberg.de.

Laura Unsöld (L)

Department of Thoracic Oncology, University Hospital Heidelberg, Thoracic Clinic, Translational Lung Research Center Heidelberg (TLRC-H), German Center for Lung Research (DZL), Heidelberg, Germany.

Nicole Deis (N)

Department of Thoracic Oncology, University Hospital Heidelberg, Thoracic Clinic, Translational Lung Research Center Heidelberg (TLRC-H), German Center for Lung Research (DZL), Heidelberg, Germany.

Katja Krug (K)

Department of General Practice and Health Services Research, University Hospital Heidelberg, Heidelberg, Germany.

Jasmin Bossert (J)

Department of General Practice and Health Services Research, University Hospital Heidelberg, Heidelberg, Germany.

Johannes Krisam (J)

Institute of Medical Biometry and Informatics, University Hospital Heidelberg, Heidelberg, Germany.

Corinna Jung (C)

Department of Thoracic Oncology, University Hospital Heidelberg, Thoracic Clinic, Translational Lung Research Center Heidelberg (TLRC-H), German Center for Lung Research (DZL), Heidelberg, Germany.
Medical School Berlin, Calandrellistr. 1-9, 12247, Berlin, Germany.

Jana Jünger (J)

Institute for Communication and Assessment Research, Medical Faculty, University Heidelberg, Heidelberg, Germany.

Michel Wensing (M)

Department of General Practice and Health Services Research, University Hospital Heidelberg, Heidelberg, Germany.

Michael Thomas (M)

Department of Thoracic Oncology, University Hospital Heidelberg, Thoracic Clinic, Translational Lung Research Center Heidelberg (TLRC-H), German Center for Lung Research (DZL), Heidelberg, Germany.

Matthias Villalobos (M)

Department of Thoracic Oncology, University Hospital Heidelberg, Thoracic Clinic, Translational Lung Research Center Heidelberg (TLRC-H), German Center for Lung Research (DZL), Heidelberg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH